hotspot -WSS

hotspot

author：explore 2025-10-01 14:59:23 - browse：583

To much of the public, the promise of telehealth is all about convenience — get the prescription you need quickly, and get it delivered right to your door. But as digital health companies build out their weight loss businesses, capitalizing on the popularity of drugs like Wegovy and Ozempic, they’re courting a very different audience: payers and employers who have a vested interest in preventing quick scripts.

Payers are reeling as they try to figure out how to sustainably cover GLP-1 receptor agonists, a class of remarkably effective but expensive obesity and type 2 diabetes drugs. So in the last six months, digital health companies including Teladoc, Found, Hello Alpha, and Calibrate have advanced enterprise products that pair virtual visits and prescriptions with lifestyle coaching. Their hope is that more and more payers and employers will offer their programs as a way to support lasting weight loss and metabolic health — or even require them if patients want their drugs reimbursed.

The competition is growing quickly. Telehealth companies once focused exclusively on consumers are now marketing to payers. Enterprise programs for chronic care management are promoting new services to support patients on obesity drugs. And companies like Noom and WeightWatchers, which have built gargantuan weight loss businesses for consumers and businesses alike, are starting to prescribe the drugs.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Medicare proposal to cover medical devices draws a mixed reaction
Next article： The White House hikes tariffs on plastic syringes made in China

WSS

Cherokee Nation medical school graduates its first class

STAT reporters are Pulitzer Prize finalists for investigative reporting

Lilly’s weekly insulin works as well as daily products, new studies show

How to fix cancer clinical trials' diversity problem

WuXi Biologics beefs up its lobbying operation

'Make People Better': The CRISPR babies story you probably don't know

leisure time

hotspot

entertainment

At least 13 dead in Texas as scorching temps continue

Boston hospital trains restaurant workers on naloxone for overdoses

At least 13 dead in Texas as scorching temps continue

Cherokee Nation medical school graduates its first class

Cancer drug shortages should be causing more outrage

Ripples from Flovent's discontinuation is killing children with asthma

How one medical school became remarkably diverse

CVS is willing to dump 10% of its Medicare Advantage members

How to save PrEP access — and even expand it

Fertility clinic egg and embryo storage is a disaster

Wikipedia

Obesity drug from Roche shows promise in early study

What a koala virus tells us about the human genome

Ethical issues complicate the benefits of medical crowdfunding

Oak Street deal isn't the answer to health care's woes

Biotech execs pursue obesity drug boom: ‘It’s the early innings’

Ripples from Flovent's discontinuation is killing children with asthma

knowledge

explore

entertainment

explore